Funding for this research was provided by:
The President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (5U2GGH000570)
Received: 13 April 2017
Accepted: 19 January 2018
First Online: 30 January 2018
Ethics approval and consent to participate
: The survey protocol was approved by the Human Sciences Research Council’s Research Ethics Committee (REC: 5/17/11/10) as well as by the Associate Director of Science of the National Centre for HIV and AIDS, Viral Hepatitis, STD and TB Prevention at the USA’s Centers for Disease Control and Prevention (CDC) in Atlanta Participants were informed of the purpose of the study. All participants provided written informed consent. Participants were guaranteed anonymity and all questionnaires and blood samples were only linked using a unique barcode.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.